Skip to main content
Premium Trial:

Request an Annual Quote

NSF Earmarks $2.5M for Biological Instrumentation Development in 2005

NEW YORK, Dec. 23 (GenomeWeb News) - That National Science Foundation has set aside $2.5 million in 2005 funding to support approximately 15 projects to develop new instrumentation for biological research.

 

According to a program solicitation issued today, the Instrument Development for Biological Research (IDBR) program "supports the development of novel or of substantially improved instrumentation likely to have a significant impact on the study of biological systems at any level."

 

Instrumentation under the program includes analytical instruments, microscopes, sensors, and "related devices for detection or measurement of biological molecules, structures, or phenomena at any level, from that of individual molecules to that of whole ecosystems." Eligible projects should aim at providing instruments with new or enhanced performance, NSF said.

 

Software "for the operation of instruments, analysis of data, or the analysis of images" will also be supported, according to the NSF, "where these have the effect of improving instrument performance."

 

Full proposals are due Oct. 5, 2005.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.